Experimental therapy of filovirus infections
- 22 January 2002
- journal article
- review article
- Published by Elsevier in Antiviral Research
- Vol. 54 (1), 1-17
- https://doi.org/10.1016/s0166-3542(02)00005-0
Abstract
No abstract availableKeywords
This publication has 62 references indexed in Scilit:
- Chemistry and Biochemistry of 2, 5-Oligoadenylate-Based Antisense StrategyCurrent Medicinal Chemistry, 2001
- The role of the Type I interferon response in the resistance of mice to filovirus infectionJournal of General Virology, 2001
- The Ebola virus VP35 protein functions as a type I IFN antagonistProceedings of the National Academy of Sciences, 2000
- Treatment of lethal Ebola virus infection in mice with a single dose of an S-adenosyl-l-homocysteine hydrolase inhibitorAntiviral Research, 2000
- Reconsidering targeted toxins to eliminate HIV infection: You gotta have HAARTProceedings of the National Academy of Sciences, 1998
- A Mouse Model for Evaluation of Prophylaxis and Therapy of Ebola Hemorrhagic FeverThe Journal of Infectious Diseases, 1998
- Discovery of cyanovirin-N, a novel human immunodeficiency virus-inactivating protein that binds viral surface envelope glycoprotein gp120: potential applications to microbicide developmentAntimicrobial Agents and Chemotherapy, 1997
- The asialoglycoprotein receptor is a potential liver-specific receptor for Marburg virusJournal of General Virology, 1995
- Antiviral immunotoxins: antibody-mediated delivery of gelonin inhibits Pichinde virus replication in vitroAntiviral Research, 1991
- Interferon Induction by Glycyrrhizin and Glycyrrhetinic Acid in MiceMicrobiology and Immunology, 1982